Fig. 3From: Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer’s diseaseModeling AD Disease using iPSCs. First, the development of suitable neuronal cell types derived from patient and control iPSC. The next step is to describe the disease phenotype using various functional and genomic analyses. High-throughput drug discovery and screening might be performed on the patient and control iPSC-derived cellsBack to article page